Contents
Current Pharmaceutical Design, Volume 14 - Number 11
Arginine Deprivation as a Targeted Therapy for Cancer
, 14(11): 1049 - 1057L. Feun, M. You, C. J. Wu, M. T. Kuo, M. Wangpaichitr, S. Spector and N. Savaraj
DOI: 10.2174/138161208784246199
Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
, 14(11): 1058 - 1077Snezana K. Bjelogrlic, Sinisa Radulovic and Nada Babovic
DOI: 10.2174/138161208784246252
Design, Synthesis and Development of Novel Camptothecin Drugs
, 14(11): 1078 - 1097Siong Tern Liew and Li-Xi Yang
DOI: 10.2174/138161208784246180
Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment
, 14(11): 1098 - 1112B. Spankuch and K. Strebhardt
DOI: 10.2174/138161208784246243
Chemosensitization of Cancer by Nitric Oxide
, 14(11): 1113 - 1123Richard Sullivan and Charles H. Graham
DOI: 10.2174/138161208784246225
Novel Approaches to Deliver Gemcitabine to Cancers
, 14(11): 1124 - 1137L. Harivardhan Reddy and Patrick Couvreur
DOI: 10.2174/138161208784246216
Locked Nucleic Acid Holds Promise in the Treatment of Cancer
, 14(11): 1138 - 1142Miriam Frieden and Henrik Orum
DOI: 10.2174/138161208784246234
Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy
, 14(11): 1143 - 1150J. Stankova, A. K. Lawrance and R. Rozen
DOI: 10.2174/138161208784246171
Webmaster Contact: info@benthamscience.org